Related Experiment Video
Updated: Mar 12, 2026
Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
Published on: April 25, 2025
Gene-expression Analysis Identifies Specific Patterns of Dysregulated Molecular Pathways and Genetic Subgroups of
Holger G Hass1, Ulrich Vogel2, Michael Scheurlen3
1Department of Oncology, Paracelsus Hospital, Scheidegg, Germany dr.holger.hass@paracelsus-kliniken.de.
Background:
Hepatocellular carcinoma comprises of a group of heterogeneous tumors of different etiologies. The multistep process of liver carcinogenesis involves various genetic and phenotypic alterations. The molecular pathways and driver mutations involved are still under investigation.
Materials And Methods:
DNA micorarray technology was used to identify differentially expressed genes between human hepatocarcinoma and non-tumorous liver tissues to establish a unique specific gene-expression profile independent of the underlying liver disease. The validity of this global gene-expression profile was tested for its robustness against biopsies from other liver entities (cirrhotic and non-cirrhotic liver) by diagnosing HCC in blinded samples.
Results:
Most of the consistently and strongly overexpressed genes were related to cell-cycle regulation and DNA replication [27 genes, e.g. cyclin B1, karyopherin alpha 2 (KPNA2), cyclin-dependent kinase 2 (CDC2)], G-protein depending signaling [e.g. Rac GTPase activating protein 1 (RACGAP1), Rab GTPase YPT1 homolog (RAB1), and ADP-ribosylation factor-like 2 (ARL2)] and extracellular matrix re-modelling or cytoskeleton structure [22 genes, e.g. serine proteinase inhibitor 1 kazal-type (SPINK1), osteopontin (OPN), secreted protein acidic and rich in cysteine (SPARC), collagen type 1 alpha2 (COL1A2), integrin alpha6 (ITGA6), and metalloproteinase 12 (MMP12)]. Furthermore, significantly differentially expressed genes (e.g. calcium-binding proteins, G-proteins, oncofetal proteins) in relation to tumor differentiation were detected using gene-expression analysis.
Conclusion:
It is suggested that these significantly dysregulated genes are highly specific and potentially utilizable as prognostic markers and may lead to a better understanding of human hepatocarcinogenesis.
Insights
Researchers identified specific gene expression profiles in hepatocellular carcinoma (HCC) tumors. These profiles, linked to cell cycle and signaling pathways, may serve as prognostic markers for liver cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Hepatocellular carcinoma (HCC) is a heterogeneous cancer with complex molecular underpinnings.
- Understanding the genetic alterations driving liver carcinogenesis is crucial for developing effective treatments.
Purpose of the Study:
- To identify a unique gene-expression profile specific to HCC, independent of underlying liver disease.
- To validate the robustness of this gene-expression profile in diagnosing HCC.
Main Methods:
- DNA microarray technology was employed to compare gene expression between HCC and non-tumorous liver tissues.
- The identified gene-expression profile was tested for diagnostic accuracy on blinded liver biopsy samples.
Main Results:
- Overexpressed genes related to cell-cycle regulation, DNA replication, G-protein signaling, and extracellular matrix remodeling were identified.
- Specific gene expression patterns correlated with tumor differentiation, including calcium-binding proteins and oncofetal proteins.
Conclusions:
- The identified dysregulated genes are highly specific to HCC.
- These genes hold potential as prognostic markers and can enhance understanding of hepatocarcinogenesis.
Related Concept Videos
01:58Cell Specific Gene Expression
01:29Pharmacogenomics: Identification of New Drug Targets